The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Survivin: A new target for anti-cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif
Crook, N. E., Clem, R. J., & Miller, L. K. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2168-2174.1993 · Cited by 1,053
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
Selenium in cancer prevention: a review of the evidence and mechanism of action
Rayman, M. P. (2005) · Proceedings of the Nutrition Society · doi:10.1079/pns2005467 · Cited by 858
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
Chromosomal passengers: conducting cell division
Ruchaud, S., Carmena, M., & Earnshaw, W. C. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2257 · Cited by 811
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Fodde, R., & Brabletz, T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.007 · Cited by 785
The role of Notch in tumorigenesis: oncogene or tumour suppressor?
Radtke, F., & Raj, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1186 · Cited by 785
Analysis of human transcriptomes
Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., et al. (1999) · Nature Genetics · doi:10.1038/70487 · Cited by 774
An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7
Shin, S., Sung, B.-J., Cho, Y.-S., Kim, H.-J., Ha, N.-C., Hwang, J.-I., Chung, C.-W., Jung, Y.-K., & Oh, B.-H. (2001) · Biochemistry · doi:10.1021/bi001603q · Cited by 674
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Resveratrol: A multitargeted agent for age-associated chronic diseases
Harikumar, K. B., & Aggarwal, B. B. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5740 · Cited by 550
Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205353 · Cited by 530
Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice
Schimmer, A. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1918 · Cited by 512
Nakahara, T., Takeuchi, M., Kinoyama, I., Minematsu, T., Shirasuna, K., Matsuhisa, A., Kita, A., Tominaga, F., Yamanaka, K., Kudoh, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1343 · Cited by 497
Olie, R. A., Simões‐Wüst, A. P., Baumann, B., Leech, S. H., Fabbro, D., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · PubMed · Cited by 489
Survivin, a cancer target with an emerging role in normal adult tissues
Fukuda, S., & Pelus, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0375 · Cited by 465
Zhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 441
Aoki, Y., Feldman, G. M., & Tosato, G. (2003) · Blood · doi:10.1182/blood-2002-07-2130 · Cited by 438
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Characterization of XIAP-Deficient Mice
Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3604-3608.2001 · Cited by 422
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma
Grossman, D., McNiff, J. M., Li, F., & Altieri, D. C. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00776.x · Cited by 365
Jeyaprakash, A. A., Klein, U. R., Lindner, D., Ebert, J., Nigg, E. A., & Conti, E. (2007) · Cell · doi:10.1016/j.cell.2007.07.045 · Cited by 351
Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells
O'Connor, D. S., Schechner, J. S., Adida, C., Mesri, M., Rothermel, A. L., Li, F., Nath, A. K., Pober, J. S., & Altieri, D. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64742-6 · Cited by 341
Rational design of shepherdin, a novel anticancer agent
Plescia, J., Salz, W., Xia, F., Pennati, M., Zaffaroni, N., Daidone, M. G., Meli, M., Dohi, T., Fortugno, P., Nefedova, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.035 · Cited by 341
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.
Noel, J. P., Verdecia, M. A., Huang, H.-K., Sonnenburg, E. D., Kaiser, D. A., & Hunter, T. R. (2000) · Nature Structural Biology · doi:10.1038/76838 · Cited by 337
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Tran, J., Rak, J., Sheehan, C., Saibil, S. D., LaCasse, E., Korneluk, R. G., & Kerbel, R. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1589 · Cited by 333
Survivin is required for stable checkpoint activation in taxol-treated HeLa cells
Carvalho, A., Carmena, M., Sambade, C., Earnshaw, W. C., & Wheatley, S. P. (2003) · Journal of Cell Science · doi:10.1242/jcs.00612 · Cited by 319
A p34cdc2 survival checkpoint in cancer
O'Connor, D. S., Wall, N. R., Porter, A. C. G., & Altieri, D. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00084-3 · Cited by 315
Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension
Lens, S. M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg307 · Cited by 310
Survivin study: What is the next wave?
Li, F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10327 · Cited by 309
Transcriptional analysis of human survivin gene expression
Li, F., & Altieri, D. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440305 · Cited by 286
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Kawasaki, H., Toyoda, M., Shinohara, H., Okuda, J., Watanabe, I., Yamamoto, T., Tanaka, K., Tenjo, T., & Tanigawa, N. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2026::aid-cncr1228>3.0.co;2-e · Cited by 279
The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner
Zhao, J., Tenev, T., Martins, L. M., Downward, J., & Lemoine, N. R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.23.4363 · Cited by 277
Zaffaroni, N., Pennati, M., Colella, G., Perego, P., Supino, R., Gatti, L., Pilotti, S., Zunino, F., & Daidone, M. G. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8518-3 · Cited by 275
Survivin: A promising tumor biomarker
Duffy, M. J., O’Donovan, N., Brennan, D. J., Gallagher, W. M., & Ryan, B. M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.020 · Cited by 267
Self-citationSuppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
Wall, N. R., O’Connor, D. S., Plescia, J., Pommier, Y. G., & Altieri, D. C. (2003) · PubMed · Cited by 252
Fulda, S., & Debatin, K.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1656 · Cited by 250
Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T., & Tokuhisa, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1457 · Cited by 244
Suzuki, A., Ito, T., Kawano, H., Hayashida, M., Hayasaki, Y., Tsutomi, Y., Akahane, K., Nakano, T., Miura, M., & Shiraki, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203429 · Cited by 232
Targeting survivin in cancer therapy: fulfilled promises and open questions
Pennati, M., Folini, M., & Zaffaroni, N. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm047 · Cited by 229
Fukuda, S., & Pelus, L. M. (2001) · Blood · doi:10.1182/blood.v98.7.2091 · Cited by 212
Blanc‐Brude, O., Mesri, M., Wall, N. R., Plescia, J., Dohi, T., & Altieri, D. C. (2003) · PubMed · Cited by 210
Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13345 · Cited by 206
Survivin as a Radioresistance Factor in Pancreatic Cancer
Asanuma, K., Moriai, R., Yajima, T., Yagihashi, A., Yamada, M., Kobayashi, D., & Watanabe, N. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00906.x · Cited by 205
Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol
Fulda, S., & Debatin, K.-M. (2004) · Oncogene · doi:10.1038/sj.onc.1207630 · Cited by 204
Survivin splice variants regulate the balance between proliferation and cell death
Caldas, H., Jiang, Y., Holloway, M. P., Fangusaro, J., Mahotka, C., Conway, E. M., & Altura, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208350 · Cited by 199
Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody
Vader, G., Kauw, J. J. W., Medema, R. H., & Lens, S. M. A. (2006) · EMBO reports · doi:10.1038/sj.embor.7400562 · Cited by 195
Tsuruma, T., Hata, F., Torigoe, T., Furuhata, T., Idenoue, S., Kurotaki, T., Yamamoto, M., Yagihashi, A., Ohmura, T., Yamaguchi, K., et al. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-19 · Cited by 181
Targeting survivin in cancer therapy
Pennati, M., Folini, M., & Zaffaroni, N. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.4.463 · Cited by 180
Cell division and cell survival in the absence of survivin
Yang, D., Welm, A., & Bishop, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406665101 · Cited by 177
Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy
Kanwar, J. R., Shen, W.-P., Kanwar, R. K., Berg, R. W., & Krissansen, G. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1541 · Cited by 172
Transcriptional analysis of human survivin gene expression
LI, F., & ALTIERI, D. C. (1999) · Biochemical Journal · doi:10.1042/bj3440305 · Cited by 171
Wang, H.-W. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2602 · Cited by 165
Wobser, M., Keikavoussi, P., Kunzmann, V., Weininger, M., Andersen, M. H., & Becker, J. C. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0102-x · Cited by 162
Xiang, R., Mizutani, N., Luo, Y., Chiodoni, C., Zhou, H., Mizutani, M., Ba, Y., Becker, J. C., & Reisfeld, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.553.65.2 · Cited by 158
Tu, S. P., JIANG, X. H., Lin, M. C. M., Cui, J. T., Yang, Y., Lum, C. T., Zou, B., Zhu, Y. B., Jiang, S. H., Wong, W. M., et al. (2003) · PubMed · Cited by 156
Identification of a novel splice variant of the human anti-apoptopsis gene survivin
Badran, A., Yoshida, A., Ishikawa, K., Goi, T., Yamaguchi, A., Ueda, T., & Inuzuka, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.178 · Cited by 150
Rödel, C. M., Haas, J., Groth, A., Grabenbauer, G. G., Sauer, R., & Rödel, F. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04618-7 · Cited by 146
Beltrami, E., Plescia, J., Wilkinson, J. C., Duckett, C. S., & Altieri, D. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309479200 · Cited by 142
Fukuda, S., Foster, R. G., Porter, S. B., & Pelus, L. M. (2002) · Blood · doi:10.1182/blood.v100.7.2463 · Cited by 136
Activation of Cancer-Specific Gene Expression by the Survivin Promoter
Bao, R., Connolly, D. C., Murphy, M., Green, J., Weinstein, J. K., Pisarcik, D. A., & Hamilton, T. C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.522 · Cited by 135
Fuessel, S., Meye, A., Schmitz, M., Zastrow, S., Linné, C., Richter, K., Löbel, B., Hakenberg, O. W., Hoelig, K., Rieber, E. P., et al. (2006) · The Prostate · doi:10.1002/pros.20404 · Cited by 123
Molecular Dependence of Estrogen Receptor–Negative Breast Cancer on a Notch-Survivin Signaling Axis
Lee, C. W., Raskett, C. M., Prudovsky, I. A., & Altieri, D. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6673 · Cited by 115
Cancer-specific activation of the survivin promoter and its potential use in gene therapy
Chen, J., Liu, J.-C., Shen, L., Rau, K.-M., Kuo, H.-P., Li, Y. M., Shi, D., Lee, Y.-C., Chang, K., & Hung, M. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700752 · Cited by 115
Survivin does not inhibit caspase-3 activity
Banks, D. P., Plescia, J., Altieri, D. C., Chen, J., Rosenberg, S. H., Zhang, H., & Ng, S. (2000) · Blood · doi:10.1182/blood.v96.12.4002.h8004000c_4002_4003 · Cited by 114
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin
Otto, K., Andersen, M. H., Eggert, A. O., Keikavoussi, P., Pedersen, L. Ø., Rath, J. C., Böck, M., Bröcker, E., Straten, P. T., Kämpgen, E., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.007 · Cited by 112
The Chromosomal Passenger Complex: One for All and All for One
Ruchaud, S., Carmena, M., & Earnshaw, W. C. (2007) · Cell · doi:10.1016/j.cell.2007.10.002 · Cited by 111
Carter, B. Z., Mak, D. H. F., Schober, W. D., Cabreira-Hansen, M. D. G., Beran, M., McQueen, T. J., Chen, W., & Andreeff, M. (2005) · Blood · doi:10.1182/blood-2004-12-4704 · Cited by 106
Ribozymes: recent advances in the development of RNA tools
Puerta‐Fernández, E., Romero‐López, C., Jesus, A. B.-D., & Berzal‐Herranz, A. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00020-2 · Cited by 106
Leung, C. G., Xu, Y., Mularski, B., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062395 · Cited by 104
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer
Ai, Z., Yin, L., Zhou, X., Zhu, Y., Zhu, D., Yu, Y., & Feng, Y. (2006) · Cancer · doi:10.1002/cncr.22044 · Cited by 101
Radiosensitization of Human Melanoma Cells by Ribozyme-Mediated Inhibition of Survivin Expression
Pennati, M., Binda, M., Colella, G., Folini, M., Villa, R., Daidone, M. G., Zaffaroni, N., & Citti, L. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12082.x · Cited by 97
Singh, R. P., Tyagi, A., Sharma, G. D., Mohan, S., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1565 · Cited by 97
Conway, E. M., Pollefeyt, S., Steiner‐Mosonyi, M., Luo, W., Vriese, A. D., Lupu, F., Bono, F., Leducq, N., Dol, F., Schaeffer, P., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34753 · Cited by 97
Survivin-Dependent Angiogenesis in Ischemic Brain
Conway, E. M., Zwerts, F., Eygen, V. V., Vriese, A. D., Nagai, N., Luo, W., & Collen, D. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63453-0 · Cited by 93
Fukuda, S., Mantel, C., & Pelus, L. M. (2003) · Blood · doi:10.1182/blood-2003-05-1756 · Cited by 89
Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras
Sommer, K. W., Schamberger, C. J., Schmidt, G., Sasgary, S., & Cerni, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206509 · Cited by 88
Tsuruma, T., Iwayama, Y., Ohmura, T., Katsuramaki, T., Hata, F., Furuhata, T., Yamaguchi, K., Kimura, Y., Torigoe, T., TOYOTA, N., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-24 · Cited by 87
The future of antisense therapy: combination with anticancer treatments
Biroccio, A., Leonetti, C., & Zupi, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206812 · Cited by 80
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin
Yonesaka, K., Tamura, K., Kurata, T., Satoh, T., Ikeda, M., Fukuoka, M., & Nakagawa, K. (2005) · International Journal of Cancer · doi:10.1002/ijc.21350 · Cited by 76
Fulda, S., & Debatin, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.020 · Cited by 74
Survivin Identifies Keratinocyte Stem Cells and Is Downregulated by Anti-β1 Integrin During Anoikis
Marconi, A., Dallaglio, K., Lotti, R., Vaschieri, C., Truzzi, F., Fantini, F., & Pincelli, C. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0165 · Cited by 73
Sharma, H., Sen, S., Muzio, L. L., Mariggiò, M. A., & Singh, N. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.7.1783 · Cited by 71
Yamamoto, T., Manome, Y., Nakamura, M., & Tanigawa, N. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00247-2 · Cited by 63
Tyagi, A., Raina, K., Singh, R. P., Gu, M., Agarwal, C., Harrison, G. S., Glodé, L. M., & Agarwal, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2006 · Cited by 63
Nakayama, Y., Sakamoto, H., Satoh, K., & Yamamoto, T. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00600-5 · Cited by 63
Zhu, N., Gu, L., Findley, H. W., Li, F., & Zhou, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208038 · Cited by 57
Phase I/II clinical safety studies of terameprocol vaginal ointment
Khanna, N., Dalby, R. N., Tan, M., Arnold, S. J., Stern, J., & Frazer, N. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.074 · Cited by 55
Mitosis-Independent Survivin Gene Expression In vivo and Regulation by p53
Xia, F., & Altieri, D. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4537 · Cited by 52
Zhu, K., Qin, H., Cha, S.-C., Neelapu, S. S., Overwijk, W. W., Lizee, G. A., Abbruzzese, J. L., Hwu, P., Radvanyi, L. G., Kwak, L. W., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.050 · Cited by 51
Peng, X., Li, Y., Yang, L., Mao, Y.-Q., Yang, H., Liu, J., Zhang, D., Chen, L.-J., & Wei, Y.-Q. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-46 · Cited by 50
Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic
Dean, E. J., Ranson, M., Blackhall, F. H., Holt, S. V., & Dive, C. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.11.002 · Cited by 50
Liu, H., Guo, S., Roll, R. L., Li, J., Diao, Z., Shao, N., Riley, M. R., Cole, A. M., Robinson, J. P., Snead, N. M., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.3962 · Cited by 48
He, S., Rehman, H., Gong, M.-G., Zhao, Y.-Z., Huang, Z., Li, C., Zhang, W., & Chen, X. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.8.4444 · Cited by 47
Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells
Bai, W., Zhang, X., Yang, T.-T., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.5.1111 · Cited by 45
Koul, D., Takada, Y., Shen, R., Aggarwal, B. B., & Yung, W. K. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.077 · Cited by 43
Wright, M. E., Han, D. K. M., & Hockenbery, D. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01962-1 · Cited by 43
Miranda, M. B., Dyer, K. F., Grandis, J. R., & Johnson, D. E. (2003) · Leukemia · doi:10.1038/sj.leu.2402779 · Cited by 38
Chemically synthesized human survivin does not inhibit caspase‐3
Li, C., Wu, Z., Liu, M., Pazgier, M., & Lu, W. (2008) · Protein Science · doi:10.1110/ps.036145.108 · Cited by 37
Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter
Chun, J. Y., Hu, Y., Pinder, E., Wu, J., Li, F., & Gao, A. C. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0172 · Cited by 37
Kim, K. W., Mutter, R. W., Willey, C. D., Subhawong, T. K., Shinohara, E. T., Albert, J. M., Geng, L., Cao, C., Gi, Y. J., & Lü, B. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.018 · Cited by 36
López, R., Goodman, A. B., Rhodes, M., Blomberg, J. A. L., & Heller, J. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32813148e0 · Cited by 31
Kappler, M., Rot, S., Taubert, H. W., Greither, T., Bartel, F., Dellas, K., Hänsgen, G., Trott, K.-R., & Bache, M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701090 · Cited by 24
Transcriptional targeting of small interfering RNAs into cancer cells
Huynh, T. T., Wälchli, S., & Sioud, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.127 · Cited by 22
Cited by
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedMitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
Survivin: A molecular biomarker in cancer
Mittal, R., Jaiswal, P., & Goel, A. (2015) · Indian Journal of Medical Research · doi:10.4103/0971-5916.159250 · Cited by 352
Role of Notch and its oncogenic signaling crosstalk in breast cancer
Guo, S., Liu, M., & Gonzalez-Perez, R. R. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.12.002 · Cited by 260
Metadata
- Authors
- Ryan, B. M., O’Donovan, N., & Duffy, M. J.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 35
- Issue
- 7
- Pages
- 553-562
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2167494923
- Cited by
- 379
- References
- 130
- FWCI
- 15.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.